Back
Agilent Technologies Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
44
A
Agilent Technologies
Last Price:
139.61
Seasonality Move:
-0.89%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
43.99
Seasonality Move:
10.8%
Sell
44
Agilent Technologies (A)
is a Sell
Is Agilent Technologies a Buy, Sell or Hold?
- The current Agilent Technologies [A] share price is $137.74. The Score for A is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- A is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $44.24. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
A Stock Price Chart
What is Agilent Technologies's stock price today?
-
The Agilent Technologies share price today is $137.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and A is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $44.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
A Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.88 | Sell |
Relative Strength Index (14 RSI): | 45.78 | Sell |
Chaikin Money Flow: | 476334 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (136.57 - 146.03) | Sell |
Bollinger Bands (100): | (130.81 - 143.53) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.09 | Sell |
Relative Strength Index (14 RSI): | 43.92 | Sell |
Chaikin Money Flow: | 101540 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.49 - 48.87) | Sell |
Bollinger Bands (100): | (43.62 - 49.46) | Sell |
A Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 135.55 | Buy |
20-day SMA: | 140.11 | Sell |
50-day SMA: | 141.38 | Sell |
200-day SMA: | 126.85 | Buy |
8-day EMA: | 137.14 | Buy |
20-day EMA: | 139.19 | Sell |
50-day EMA: | 139.52 | Sell |
200-day EMA: | 132.21 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.87 | Buy |
20-day SMA: | 46.21 | Sell |
50-day SMA: | 47.79 | Sell |
200-day SMA: | 42.13 | Buy |
8-day EMA: | 44.35 | Sell |
20-day EMA: | 45.49 | Sell |
50-day EMA: | 46.38 | Sell |
200-day EMA: | 44.57 | Sell |
Agilent Technologies Earnings Growth & A Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.09 per share, and an increase next year of $0.58 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $0.95 per share.
Agilent Technologies Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |